Recent Finacing
Recent Raise
Bridge Medicines is a drug discovery company advancing early-stage in-licensed oncology and inflammatory therapies to clinic, developing ENL-YEATS inhibitors for acute leukemias and oral FXII inhibitors for hereditary angioedema.